256 related articles for article (PubMed ID: 18251716)
1. Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region.
Fujisawa D; Yamazaki Y; Lomonte B; Morita T
Biochem J; 2008 May; 411(3):515-22. PubMed ID: 18251716
[TBL] [Abstract][Full Text] [Related]
2. C-terminal heparin-binding peptide of snake venom VEGF specifically blocks VEGF-stimulated endothelial cell proliferation.
Yamazaki Y; Tokunaga Y; Takani K; Morita T
Pathophysiol Haemost Thromb; 2005; 34(4-5):197-9. PubMed ID: 16707927
[TBL] [Abstract][Full Text] [Related]
3. Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165.
Yamazaki Y; Tokunaga Y; Takani K; Morita T
Biochemistry; 2005 Jun; 44(24):8858-64. PubMed ID: 15952792
[TBL] [Abstract][Full Text] [Related]
4. Identification of vascular endothelial growth factor receptor-binding protein in the venom of eastern cottonmouth. A new role of snake venom myotoxic Lys49-phospholipase A2.
Yamazaki Y; Matsunaga Y; Nakano Y; Morita T
J Biol Chem; 2005 Aug; 280(34):29989-92. PubMed ID: 16014630
[TBL] [Abstract][Full Text] [Related]
5. Characterization and development of a peptide substrate-based phosphate transfer assay for the human vascular endothelial growth factor receptor-2 tyrosine kinase.
Zhao G; Peery RB; Yingling JM
Anal Biochem; 2007 Jan; 360(2):196-206. PubMed ID: 17141171
[TBL] [Abstract][Full Text] [Related]
6. Myotoxic phospholipases A(2) isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: cytotoxic effect on microorganism and tumor cells.
Costa TR; Menaldo DL; Oliveira CZ; Santos-Filho NA; Teixeira SS; Nomizo A; Fuly AL; Monteiro MC; de Souza BM; Palma MS; Stábeli RG; Sampaio SV; Soares AM
Peptides; 2008 Oct; 29(10):1645-56. PubMed ID: 18602430
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding.
Iyer S; Scotney PD; Nash AD; Ravi Acharya K
J Mol Biol; 2006 May; 359(1):76-85. PubMed ID: 16616187
[TBL] [Abstract][Full Text] [Related]
9. Investigating the differential activation of vascular endothelial growth factor (VEGF) receptors.
Horta BA; Sodero AC; de Alencastro RB
J Mol Graph Model; 2009 Oct; 28(3):287-96. PubMed ID: 19734078
[TBL] [Abstract][Full Text] [Related]
10. A novel phospholipase A2 from Agkistrodon blomhoffii ussurensis venom: purification, proteomic, functional and structural characterizations.
Sun MZ; Liu S; Yang F; Greenaway FT; Xu Y
Biochimie; 2009 Apr; 91(4):558-67. PubMed ID: 19278623
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of a novel myotoxic Arg49 phospholipase A2 homolog (zhaoermiatoxin) from Zhaoermia mangshanensis snake venom: insights into Arg49 coordination and the role of Lys122 in the polarization of the C-terminus.
Murakami MT; Kuch U; Betzel C; Mebs D; Arni RK
Toxicon; 2008 Apr; 51(5):723-35. PubMed ID: 18295812
[TBL] [Abstract][Full Text] [Related]
12. Identification and localization of heparin-binding region of snake venom VEGF and its blocking of VEGF-A165.
Tokunaga Y; Yamazaki Y; Morita T
Pathophysiol Haemost Thromb; 2005; 34(4-5):194-6. PubMed ID: 16707926
[TBL] [Abstract][Full Text] [Related]
13. Isolation and functional characterization of a new myotoxic acidic phospholipase A(2) from Bothrops pauloensis snake venom.
Rodrigues RS; Izidoro LF; Teixeira SS; Silveira LB; Hamaguchi A; Homsi-Brandeburgo MI; Selistre-de-Araújo HS; Giglio JR; Fuly AL; Soares AM; Rodrigues VM
Toxicon; 2007 Jul; 50(1):153-65. PubMed ID: 17451767
[TBL] [Abstract][Full Text] [Related]
14. Preparation of extracellular domain 3 of human VEGF receptor-2 and the monitoring of its real-time binding to VEGF by biosensors.
Zhang J; Li H; Chen W; Cao P; Wang M
Biotechnol Prog; 2009; 25(6):1703-8. PubMed ID: 19731341
[TBL] [Abstract][Full Text] [Related]
15. [Expression and function identification of extracellular domain 3 of human vascular endothelial growth factor receptor KDR].
Zhang J; Zhang Y; Li H; Chen W; Zhang T; Wang M
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1962-7. PubMed ID: 19256346
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of an acidic phospholipase A(2) from Bothrops pirajai snake venom: synthetic C-terminal peptide identifies its antiplatelet region.
Teixeira SS; Silveira LB; da Silva FM; Marchi-Salvador DP; Silva FP; Izidoro LF; Fuly AL; Juliano MA; dos Santos CR; Murakami MT; Sampaio SV; da Silva SL; Soares AM
Arch Toxicol; 2011 Oct; 85(10):1219-33. PubMed ID: 21331602
[TBL] [Abstract][Full Text] [Related]
17. The comparison of VEGFR-1-binding domain of VEGF-A with modelled VEGF-C sheds light on receptor specificity.
Kasap M; Sazci A
J Theor Biol; 2008 Aug; 253(3):446-51. PubMed ID: 18479712
[TBL] [Abstract][Full Text] [Related]
18. Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR).
Böldicke T; Weber H; Mueller PP; Barleon B; Bernal M
J Immunol Methods; 2005 May; 300(1-2):146-59. PubMed ID: 15946674
[TBL] [Abstract][Full Text] [Related]
19. [Prokaryotic expression and characterization of an anti-KDR single chain antibody].
Li R; Xiong DS; Xu YF; Shao XF; Fan DM; Zhu ZP; Yang CZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):39-42. PubMed ID: 15629080
[TBL] [Abstract][Full Text] [Related]
20. Human/mouse cross-reactive anti-VEGF receptor 2 recombinant antibodies selected from an immune b9 allotype rabbit antibody library.
Popkov M; Jendreyko N; Gonzalez-Sapienza G; Mage RG; Rader C; Barbas CF
J Immunol Methods; 2004 May; 288(1-2):149-64. PubMed ID: 15183093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
